|
The editorial in the February issue of Allergy identified the new areas of research in the field of allergology. The constantly growing world wide incidences of allergic manifestations are increasingly of a cellular or multi-factorial type and less of an Immunoglobulin E linked type. This means that a new paradigm must be formulated in order to deal with them.
For years, we have been discussing allergies as multi-factorial phenomena and not just ones that are linked to IgE production. We come in contact with it every day and we understand it by the way in which people recover thanks to a combination of work on the allergen, changes in diet, emotional support and the use of minerals and soft therapies. All of this amounts to a unified conception centered on re-balancing that reaches out to the various areas of each person.
The editorial published in the last issue of Allergy (Bousquet J et al, Allergy 2008 Feb;63(2):143-7) expresses the same concept. The opening pages of the magazine, which include the contributions of the most accredited European experts in allergology, call for the need to no longer study allergy from only one point of view. In particular, there are some noteworthy references to emerging pathologies whose purely IgE-related diagnosis has been shown to be meaningless:
Non-allergic rhinitis (a phenomenon that affects around 200 million people in the Western civilization).
-
Critical and severe asthma ( in spite of the classic therapies that are usually effective, and therefore characterized by a pathogenic condition that is different from that which was imagined up to now).
-
Non-allergic eczema (30% of undocumented dermatitis cases produce classic allergic responses)
-
Diffused inflammation (growing phenomena, of undefined origin, surely linked to allergy but expressed in ways that are not yet clear).
Even if we limit ourselves to only these 4 clinical elements, we'll be referring to around half of the worldwide population. Eurosalus has always worked on this aspect, combining an allergological study that takes into consideration individual threshold level , non-allergic inflammation, and new routes of allergy that have been recently redefined.
Fortunately, there are people who are working on these themes regardless of the ostracism that comes from many of our Italian colleagues who raise objections despite the most obvious scientific proof. They defend themselves in the name of "science" which they evidently know nothing about. There's a lot of work to be done, we just need to roll up our sleeves and look reality in the face instead of trying to invent it...
|
News for meds 
